Allogene Therapeutics(ALLO)
$0.90-0.03 (-3.33%)
ALLO
Allogene Therapeutics Revenue
$0.90
At close:-0.03 (-3.33%)
Want to see ALLO full AI Analyst Report?
Allogene Therapeutics (ALLO) Revenue
1,852 Followers
Allogene Therapeutics Revenue
Allogene Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 4.64M, Increased 0.00%. In the fiscal year ending Dec 31, 2025, Allogene Therapeutics had annual revenue of 0.00 with -100.00% growth.
- Revenue (ttm)
- 4.64M
- Revenue Growth
- ―
- P/S Ratio
- ―
- Revenue/Employee
- $0
- Employees
- 151
- Market Cap
- $322.87M
Revenue Chart
Allogene Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 0.00 | -22.00K | -100.00% |
| Dec 31, 2024 | 22.00K | -73.00K | -76.84% |
| Dec 31, 2023 | 95.00K | -61.00K | -39.10% |
| Dec 31, 2022 | 156.00K | -113.93M | -99.86% |
| Dec 31, 2021 | 114.09M | 114.09M | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.